相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma
Satyen H. Gohil et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
A systematic review identifies valid comorbidity indices derived from administrative health data
Marko Yurkovich et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
Ayman Saad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009
Jan Sjoberg et al.
BLOOD (2012)
A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era
Andrew M. Evens et al.
BLOOD (2012)
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study
Stephen J. Proctor et al.
BLOOD (2012)
Classical Hodgkin's lymphoma arising in different host's conditions: Pathobiology parameters, therapeutic options, and outcome
Antonino Carbone et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma
W. J. Plattel et al.
BONE MARROW TRANSPLANTATION (2011)
High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma
N. Puig et al.
BONE MARROW TRANSPLANTATION (2011)
The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma
Teresa V. Halbsguth et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2011)
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age
C. Hosing et al.
ANNALS OF ONCOLOGY (2008)
Utility of comorbidity assessment in predicting transplantation-related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma
Laura Labonte et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma
Tanya M. Wildes et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer Registry
DJ van Spronsen et al.
EUROPEAN JOURNAL OF CANCER (2005)
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease:: a randomised trial
N Schmitz et al.
LANCET (2002)
Autologous stem-cell transplantation for Hodgkin's disease:: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group
A Sureda et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
HM Lazarus et al.
BONE MARROW TRANSPLANTATION (2001)
分享论文
